title: [Streptococcus pyogenes an emerging pathogen].
authors.forename: R
authors.initials: R
authors.lastname: Cohen
authors.forename: Y
authors.initials: Y
authors.lastname: Aujard
authors.forename: P
authors.initials: P
authors.lastname: Bidet
authors.forename: A
authors.initials: A
authors.lastname: Bourrillon
authors.forename: E
authors.initials: E
authors.lastname: Bingen
authors.forename: P
authors.initials: P
authors.lastname: Foucaud
authors.forename: M
authors.initials: M
authors.lastname: François
authors.forename: J M
authors.initials: JM
authors.lastname: Garnier
authors.forename: D
authors.initials: D
authors.lastname: Gendrel
authors.forename: M
authors.initials: M
authors.lastname: Guillot
authors.forename: I
authors.initials: I
authors.lastname: Hau
authors.forename: C
authors.initials: C
authors.lastname: Olivier
authors.forename: B
authors.initials: B
authors.lastname: Quinet
authors.forename: J
authors.initials: J
authors.lastname: Raymond
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D013297:Streptococcus pyogenes / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D047090:beta-Lactams / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D047090:beta-Lactams; D002981:Clindamycin